Profile
Presently, Terry-Ann Burrell holds the position of Chief Financial Officer & Treasurer of Beam Therapeutics, Inc. Ms. Burrell is also on the board of Recursion Pharmaceuticals, Inc. In her past career she occupied the position of Managing Director at JPMorgan Securities LLC. Ms. Burrell received an undergraduate degree from Harvard University and an MBA from The Leonard N Stern School of Business.
Former positions of Terry-Ann Burrell
| Companies | Position | End |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 11/08/2024 |
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 08/08/2024 |
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 07/08/2024 |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/07/2019 |
Training of Terry-Ann Burrell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Terry-Ann Burrell
















